Table 2.

Summary of baseline data collection for the feasibility randomised controlled trial

Demographics	Age, sex, ethnicity, religion, marital status + / − children, employment status, education level, housing tenure, EIMD 2019 score, distances lived from kidney hospital and transplanting hospital, car ownership, alcohol consumption, smoking history
Clinical	Primary renal disease, date of current transplant listing, comorbidities, current stage of kidney disease (pre-emptive, haemodialysis, peritoneal dialysis), body mass index (BMI)
Patient reported	Renal and transplant knowledge (R3K-T [41]), social support (ISEL-12 [42, 43]), patient activation (PAM13 [26, 44]), health literacy (SILS [45, 46]), transplant preference, transplant beliefs [47], experience talking to family and friends about kidney disease and living donation (binary response questions), quality of life (EQ-5D-5L [48])
Laboratory	Blood group, tissue type at HLA-A, B and DR, matchability (levels 1–10), % calculated reaction frequency
Family and social network	Draw sociogram/social network diagram — containing information on all close relationships with relatives and friends and the estimated age, sex and health of these social contacts